Peptide GHK-CU Cream
US$ 27.92
aod9604 clinical trials AOD-9604 AOD 9604 Peptide: The Complete
Description
The dose figures above are the documented per-dose amounts
The Bcl-2/Bax ratio increased and cleaved caspase-3 levels dropped, indicating reduced apoptosis (Pyo et al., 2007)
Clinical trials confirmed that AOD-9604 has no negative impact on glucose metabolism, representing a significant safety advantage for individuals with metabolic concerns
Because each format works differently, the safest way to think about GHK-Cu dosage is by delivery method, not by one universal number
